Pharmacy

The Biden administration is pushing for vaccine-makers to tweak their vaccines for better efficacy against omicron subvariants BA.4 and BA.5 while suppressing efforts to deploy a second booster to adults younger than 50, The Washington Post reported July 22. 

For months, legislators have chipped away at President Joe Biden's Build Back Better Act, with the resulting leftovers centering around lowering drug costs for Medicare and Medicaid beneficiaries, according to The Washington Post.

About four weeks after the Supreme Court reversed the national right to an abortion, the House passed legislation July 21 to secure the right to contraceptives, according to CNBC. 

When the FDA declared pharmacists could prescribe Pfizer's antiviral treatment directly to patients in early July, it caused a flurry of mixed reactions among the healthcare industry. The widespread staffing shortage could be halting the process, though. 

As the World Health Organization continues its rollout of the first authorized malaria vaccine, one of the key investors has pulled out because of the vaccine's low efficacy, according to The Washington Post.

Now that Novavax has entered the COVID-19 vaccine scene, here's a rundown of the similarities and differences among each vaccine option, according to Yale Medicine:

After more than a year of Pfizer, Moderna and Johnson & Johnson shots going into people's arms, there's now a fourth vaccine option. 

The executive vice president and general counsel of Johnson & Johnson, Michael Ullman, MD, plans to retire by the end of 2022 and will be succeeded by Elizabeth Forminard, effective Oct. 17.

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

The hashtag "BoycottWalgreens" has flooded social media after a customer took to Twitter earlier this month, alleging a Walgreens worker refused to sell condoms because of religious reasons.